Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review

Date: June 21, 2016
Pages: 39
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: K2F40EA8740EN
Leaflet:

Download PDF Leaflet

Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review
Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Kobayashi Pharmaceutical Co., Ltd. (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, sanitary products, household sundries, and body warmers. It also offers health food products, dietary food products, and nutritional supplements and skin care products. Furthermore, the company manufactures, imports and markets medical equipment, devices and ventilators to medical institutes and hospitals in Japan. Kobayashi through its mail order business or direct marketing business sells nutrition supplemental foods, and skin care products. The company produces synthetic resin products and also provides transportation, insurance, production, advertising planning, and real estate management services. It operates through its subsidiaries and has presence in North America, Europe, Asian countries. Kobayashi is headquartered in Chuo-ku, Osaka, Japan.

Kobayashi Pharmaceutical Co Ltd Key Recent Developments

Apr 30, 2015: Kobayashi Pharmaceutical Announces Financial Results For Fiscal Year Ended March 31, 2015
Jan 29, 2015: Summary of Financial Statements (Japanese GAAP) (Consolidated) Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Kobayashi Pharmaceutical Co Ltd - Key Facts
Kobayashi Pharmaceutical Co Ltd - Key Employees
Kobayashi Pharmaceutical Co Ltd - Key Employee Biographies
Kobayashi Pharmaceutical Co Ltd - Major Products and Services
Kobayashi Pharmaceutical Co Ltd - History
Kobayashi Pharmaceutical Co Ltd - Company Statement
Kobayashi Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Kobayashi Pharmaceutical Co Ltd - Business Description
Kobayashi Pharmaceutical Co Ltd - Corporate Strategy
Kobayashi Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Kobayashi Pharmaceutical Co Ltd - Strengths
Strength - Core Segment: Consumer Products Business
Strength - Focused Research and Development Activities
Kobayashi Pharmaceutical Co Ltd - Weaknesses
Weakness - Declined Direct Marketing Business Performance
Kobayashi Pharmaceutical Co Ltd - Opportunities
Opportunity - Growing Demand for Skin Protective Products
Opportunity - Increasing Healthcare Expenditure
Opportunity - New Product Launches
Kobayashi Pharmaceutical Co Ltd - Threats
Threat - Stringent Government Regulations
Threat - Growing Parallel Trade
Threat - Dependency on wheather condition
Kobayashi Pharmaceutical Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Kobayashi Pharmaceutical Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 30, 2015: Kobayashi Pharmaceutical Announces Financial Results For Fiscal Year Ended March 31, 2015
Jan 29, 2015: Summary of Financial Statements (Japanese GAAP) (Consolidated) Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2015

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Kobayashi Pharmaceutical Co Ltd, Key Facts
Kobayashi Pharmaceutical Co Ltd, Key Employees
Kobayashi Pharmaceutical Co Ltd, Key Employee Biographies
Kobayashi Pharmaceutical Co Ltd, Major Products and Services
Kobayashi Pharmaceutical Co Ltd, History
Kobayashi Pharmaceutical Co Ltd, Subsidiaries
Kobayashi Pharmaceutical Co Ltd, Joint Venture
Kobayashi Pharmaceutical Co Ltd, Key Competitors
Kobayashi Pharmaceutical Co Ltd, Ratios based on current share price
Kobayashi Pharmaceutical Co Ltd, Annual Ratios
Kobayashi Pharmaceutical Co Ltd, Interim Ratios
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Kobayashi Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Kobayashi Pharmaceutical Co Ltd, Performance Chart (2012 - 2016)
Kobayashi Pharmaceutical Co Ltd, Ratio Charts
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Kobayashi Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Wakamoto Pharmaceutical Co., Ltd.
Soiken Holdings Inc.
Sinopharm Group Co. Ltd.
Shionogi & Co., Ltd.
Seikagaku Corporation
Matsumotokiyoshi Holdings Co., Ltd.
Kao Corporation
GlaxoSmithKline Plc
Chugai Pharmaceutical Co., Ltd.
Astellas Pharma Inc.
Alfresa Holdings Corporation
Abbott Laboratories
Skip to top


Ask Your Question

Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: